300233 logo

Shandong Jincheng Pharmaceutical Group Co., Ltd Stock Price

SZSE:300233 Community·CN¥7.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300233 Share Price Performance

CN¥18.60
3.07 (19.77%)
CN¥18.60
3.07 (19.77%)
Price CN¥18.60

300233 Community Narratives

There are no narratives available yet.

Recent 300233 News & Updates

Shandong Jincheng Pharmaceutical Group Co., Ltd Key Details

CN¥3.0b

Revenue

CN¥1.9b

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥958.9m

Other Expenses

CN¥109.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 27, 2025
Earnings per share (EPS)
0.29
Gross Margin
35.91%
Net Profit Margin
3.68%
Debt/Equity Ratio
9.7%

Shandong Jincheng Pharmaceutical Group Co., Ltd Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

2 Risks
0 Rewards

About 300233

Founded
2004
Employees
3657
CEO
Jiaquan Li
WebsiteView website
www.jinchengpharm.com

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.4%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. In the last year, the market has climbed 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›